🔎 Trials Near Me

Akèy › Migrèn › Pennsylvania

Etid klinik pou Migrèn nan Pennsylvania

8 etid pou Migrèn ap chèche patisipan nan sit nan Pennsylvania.

Vil nan Pennsylvania

Tèks ofisyèl etid la (Anglè)

A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

  • Children's Hospital of Philadelphia, Philadelphia
Ap rekriteFaz 1
Laj 6 a 11 · Tout sèks · Mizajou Sep 28, 2026 · NCT06995729

MMA Embolization for Refractory Chronic Migraine

  • Thomas Jefferson University Hospital, Philadelphia
Ap rekrite
Laj 18 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT06735833

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

  • Clario, Philadelphia
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT04649242

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

  • The Children's Hospital of Philadelphia /ID# 270842, Philadelphia
  • Frontier Clinical Research - Scottdale /ID# 270854, Scottdale
  • Frontier Clinical Research - Smithfield /ID# 270849, Smithfield
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Sep 22, 2026 · NCT06810505

Responding With Evidence and Access for Childhood Headaches

  • Children's Hospital of Philadelphia, Philadelphia
Ap rekrite
Laj 10 a 17 · Tout sèks · Mizajou Sep 21, 2026 · NCT05889624

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

  • University of Pennsylvania, Philadelphia
Ap rekriteFaz 4
Laj 18 a 70 · Tout sèks · Mizajou Sep 16, 2026 · NCT06972056

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

  • Children's Hospital of Philadelphia - Main /ID# 232487, Philadelphia
  • Frontier Clinical Research - Scottdale /ID# 231913, Scottdale
  • Frontier Clinical Research - Smithfield /ID# 231912, Smithfield
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 14, 2026 · NCT05125302

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  • Lehigh Center for Clinical Research, Allentown
  • Clinical Research Philadelphia, Philadelphia
  • Preferred Primary Care Physicians, Inc., Pittsburgh
  • ak 2 plis
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 20, 2026 · NCT07645924

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.